ULBI
Ultralife Corporation
6.10$
+2.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +12.8% | -5.9% | +2.5% | -17.0% | +22.9% | +15.7% | -4.3% | -10.7% | +11.8% | -2.1% | +1.0% | – | |
| – | +11.6% | -8.1% | +3.2% | -14.0% | +23.1% | +15.5% | -2.7% | -8.6% | +7.5% | +2.4% | -9.4% | – | |
| – | +16.7% | +0.6% | +0.8% | -24.9% | +22.1% | +16.4% | -9.3% | -17.7% | +27.8% | -16.3% | +40.9% | – | |
| – | -0.9% | -5.2% | +13.7% | +5.2% | +14.9% | -16.0% | -4.3% | +27.6% | +3.4% | +15.5% | +9.1% | – | |
| – | +2.3% | -4.2% | 0.0% | +7.5% | +10.6% | +3.4% | +1.2% | +9.8% | -0.7% | -3.9% | -2.2% | – | |
| – | +1.5% | -4.5% | +3.2% | +6.9% | +418.6% | -78.9% | -0.1% | +13.7% | -11.4% | +11.7% | +3.7% | – | |
| – | +70.9% | +11.3% | -3.6% | -87.0% | +188.5% | +130.6% | -33.6% | -142.2% | – | -107.8% | – | – | |
| – | -3.4% | -8.1% | -19.6% | -58.6% | +379.2% | +24.5% | -3.9% | +0.0% | -5.5% | -7.4% | -3.3% | – | |
| – | +78.0% | +15.9% | +6.6% | -90.8% | +40.2% | +394.1% | -54.5% | -257.3% | – | – | – | – | |
| – | -41.0% | +167.3% | +21.3% | -91.3% | – | – | -57.1% | -307.4% | – | – | – | – | |
| – | +116.0% | +0.6% | +2.7% | -91.3% | -24.8% | +861.3% | -52.9% | -238.8% | – | – | – | – | |
| – | +39.8% | +9.7% | +3.6% | -71.2% | – | – | -27.1% | -81.3% | -1,306.4% | – | +237.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.